Cargando…
Willingness to report treatment-related symptoms of immunotherapy among patients with non-small cell lung cancer
PURPOSE: Immunotherapy is an evolving therapeutic approach for non-small cell lung cancer (NSCLC). This study explored factors involved in patients’ perceptions about reporting or not reporting treatment-related symptoms experienced while undergoing immunotherapy. METHODS: Patients receiving immunot...
Autores principales: | Martin, Mona L., Chung, Helena, Rydén, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960557/ https://www.ncbi.nlm.nih.gov/pubmed/34383226 http://dx.doi.org/10.1007/s11136-021-02966-3 |
Ejemplares similares
-
How patients being treated for non-small cell lung cancer value treatment benefit despite side effects
por: Martin, Mona L., et al.
Publicado: (2021) -
Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
por: Walding, Andrew, et al.
Publicado: (2022) -
Correction to: Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
por: Walding, Andrew, et al.
Publicado: (2022) -
Immunotherapy and the Treatment of Non–Small Cell Lung Cancer
por: Walker, Suzanne
Publicado: (2016) -
Immunotherapy for Non-Small Cell Lung Cancer
por: Yoon, Sung Ho
Publicado: (2014)